Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Alexei Basnakian to Lipoproteins, LDL

This is a "connection" page, showing publications Alexei Basnakian has written about Lipoproteins, LDL.

 
Connection Strength
  
 
 
2.681
  
  1. Mehta JL, Basnakian AG. Interaction of carbamylated LDL with LOX-1 in the induction of endothelial dysfunction and atherosclerosis. Eur Heart J. 2014 Nov 14; 35(43):2996-7.
    View in: PubMed
    Score: 0.419
  2. Apostolov EO, Ok E, Burns S, Nawaz S, Savenka A, Shah S, Basnakian AG. Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophages. J Atheroscler Thromb. 2013; 20(12):878-92.
    View in: PubMed
    Score: 0.405
  3. Apostolov EO, Ray D, Savenka AV, Shah SV, Basnakian AG. Chronic uremia stimulates LDL carbamylation and atherosclerosis. J Am Soc Nephrol. 2010 Nov; 21(11):1852-7.
    View in: PubMed
    Score: 0.330
  4. Basnakian AG, Shah SV, Ok E, Altunel E, Apostolov EO. Carbamylated LDL. Adv Clin Chem. 2010; 51:25-52.
    View in: PubMed
    Score: 0.312
  5. Apostolov EO, Shah SV, Ray D, Basnakian AG. Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol. 2009 Oct; 29(10):1622-30.
    View in: PubMed
    Score: 0.305
  6. Apostolov EO, Shah SV, Ok E, Basnakian AG. Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2007 Apr; 27(4):826-32.
    View in: PubMed
    Score: 0.255
  7. Apostolov EO, Shah SV, Ok E, Basnakian AG. Quantification of carbamylated LDL in human sera by a new sandwich ELISA. Clin Chem. 2005 Apr; 51(4):719-28.
    View in: PubMed
    Score: 0.222
  8. Apostolov EO, Basnakian AG, Ok E, Shah SV. Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease. J Ren Nutr. 2012 Jan; 22(1):134-8.
    View in: PubMed
    Score: 0.090
  9. Apostolov EO, Ray D, Alobuia WM, Mikhailova MV, Wang X, Basnakian AG, Shah SV. Endonuclease G mediates endothelial cell death induced by carbamylated LDL. Am J Physiol Heart Circ Physiol. 2011 Jun; 300(6):H1997-2004.
    View in: PubMed
    Score: 0.085
  10. Asci G, Basci A, Shah SV, Basnakian A, Toz H, Ozkahya M, Duman S, Ok E. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology (Carlton). 2008 Dec; 13(6):480-6.
    View in: PubMed
    Score: 0.070
  11. Shah SV, Apostolov EO, Ok E, Basnakian AG. Novel mechanisms in accelerated atherosclerosis in kidney disease. J Ren Nutr. 2008 Jan; 18(1):65-9.
    View in: PubMed
    Score: 0.068
  12. Apostolov EO, Basnakian AG, Yin X, Ok E, Shah SV. Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1836-46.
    View in: PubMed
    Score: 0.063
  13. Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 2005 Jul; 68(1):173-8.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.